CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-06 | Schuth Alexander O. COO and Secretary | Sale | −10,000 | $76.20 | $762K | 491,582 |
| 2021-07-01 | Watts Ryan J. President and CEO | Sale | −3,030 | $76.38 | $231K | 2,207,712 |
| 2021-07-01 | Watts Ryan J. President and CEO | Sale | −12,844 | $77.35 | $993K | 2,194,868 |
| 2021-07-01 | Watts Ryan J. President and CEO | Sale | −2,459 | $77.84 | $191K | 2,192,409 |
| 2021-06-23 | SATO VICKI L Director | Sale | −680 | $70.20 | $48K | 135,483 |
| 2021-06-23 | SATO VICKI L Director | Sale | −986 | $71.11 | $70K | 134,497 |
| 2021-06-07 | Tessier-Lavigne Marc Director | Option exercise | +39,303 | $18.00 | $707K | 2,583,673 |
| 2021-06-07 | Tessier-Lavigne Marc Director | Option exercise | +27,830 | $18.92 | $527K | 2,611,503 |
| 2021-06-07 | Tessier-Lavigne Marc Director | Option exercise | +27,245 | $19.50 | $531K | 2,638,748 |
| 2021-06-07 | Tessier-Lavigne Marc Director | Sale | −93,678 | $70.35 | $6.6M | 2,545,070 |
| 2021-06-07 | Tessier-Lavigne Marc Director | Sale | −700 | $71.06 | $50K | 2,544,370 |
| 2021-06-07 | Tessier-Lavigne Marc Director | Option exercise · Stock Option (right to buy) | −39,303 | 7,862 | ||
| 2021-06-07 | Tessier-Lavigne Marc Director | Option exercise · Stock Option (right to buy) | −27,830 | 0 | ||
| 2021-06-07 | Tessier-Lavigne Marc Director | Option exercise · Stock Option (right to buy) | −27,245 | 0 | ||
| 2021-06-04 | Schuth Alexander O. COO and Secretary | Sale | −5,660 | $64.35 | $364K | 505,922 |
| 2021-06-04 | Schuth Alexander O. COO and Secretary | Sale | −4,340 | $64.82 | $281K | 501,582 |
| 2021-06-02 | Tessier-Lavigne Marc Director | Grant or award | +2,074 | 2,544,370 | ||
| 2021-06-02 | Tessier-Lavigne Marc Director | Grant or award · Stock Option (right to buy) | +6,222 | 6,222 | ||
| 2021-06-02 | Schenkein David P Director | Grant or award | +2,074 | 5,327 | ||
| 2021-06-02 | Schenkein David P Director | Grant or award · Stock Option (right to buy) | +6,222 | 6,222 |
Page 21 of 53 · 1,053 trades